Tianyin Pharmaceutical Co Stock Price To Earning
Tianyin Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianyin Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianyin Stock. The fundamental analysis module provides a way to measure Tianyin Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianyin Pharmaceutical stock.
Tianyin |
Tianyin Pharmaceutical Co Company Price To Earning Analysis
Tianyin Pharmaceutical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Tianyin Pharmaceutical Price To Earning | 3.34 X |
Most of Tianyin Pharmaceutical's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianyin Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Tianyin Pharmaceutical Co has a Price To Earning of 3.34 times. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The price to earning for all United States stocks is notably lower than that of the firm.
Tianyin Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianyin Pharmaceutical's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics of similar companies.Tianyin Pharmaceutical is currently under evaluation in price to earning category among its peers.
Tianyin Fundamentals
Return On Asset | -1.24 | |||
Profit Margin | (13.72) % | |||
Operating Margin | (7.06) % | |||
Current Valuation | (7.22 M) | |||
Shares Outstanding | 29.43 M | |||
Shares Owned By Insiders | 26.44 % | |||
Shares Owned By Institutions | 6.40 % | |||
Number Of Shares Shorted | 112.52 K | |||
Price To Earning | 3.34 X | |||
Price To Book | 0.05 X | |||
Price To Sales | 0.17 X | |||
Revenue | 29.64 M | |||
Gross Profit | 15.88 M | |||
Net Income | (4.07 M) | |||
Cash And Equivalents | 15.16 M | |||
Cash Per Share | 0.52 X | |||
Total Debt | 2.94 M | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 6.64 X | |||
Cash Flow From Operations | (1.25 M) | |||
Earnings Per Share | (0.14) X | |||
Number Of Employees | 1 K | |||
Beta | 2.79 | |||
Total Asset | 101.35 M | |||
Retained Earnings | 50.19 M | |||
Working Capital | 23.39 M | |||
Current Asset | 27.53 M | |||
Current Liabilities | 4.15 M |
Currently Active Assets on Macroaxis
EBR | Centrais Electricas Brasileiras | |
HE | Hawaiian Electric Industries | |
VFC | VF Corporation | |
BVHMF | Vistry Group PLC | |
S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |